May 11, 2021 | Clinical case

Compare your opinion with peers and Mr. Hugh Mostafid

Which biomarker metric is dependent on disease prevalence, and therefore cannot be compared between different cohorts?

Submit your answer and read the opinion of Mr. Hugh Mostafid.

A) Sensitivity

B) NPV*

* negative predictive value

C) Specificity

Download the free slide resource and brochure

Download the brochure

All updates

Other updates

Urinary biomarkers for the surveillance of NMIBC

Nov 3, 2026 | Lecture

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

Compare your opinion with peers and Prof. Joost Boormans

Feb 16, 2026 | Clinical case

Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for painless haematuria. The pathology report indicated pTa grade 2,...

Improving detection of high-grade recurrences missed by WLC using a urinary biomarker

Jan 16, 2026 | Publication

Improving detection of high-grade recurrences missed by WLC using a urinary biomarkerReviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine white-light cystoscopy (WLC) and urinary cytology as the diagnostic...